Abstract:ABSTRACT Since Porcine Circovirus 3 (PCV3) was first identified in 2016, our understanding of the humoral response is still relatively scarce. Current knowledge of the PCV3 humoral response is primarily based on field studies identifying the seroprevalence of PCV3 Cap-induced antibodies. Studies on the humoral response following experimental PCV3 infection have conflicting results where one study reports the development of the Cap IgG response 7 days postinfection with no concurrent Cap IgM response, while a second study shows a Cap IgM response at the same time point with no detection of Cap IgG. The dynamics of the PCV3 Cap and Rep IgG following maternal antibody transfer and experimental infection have not been well characterized. Additionally, the cross-reactivity of convalescent serum from PCV2 and PCV3 experimentally infected animals to serologic methods of the alternate PCV has limited evaluation. Here, we show that maternally derived antibodies were detectable in piglet serum 7–9 weeks postfarrowing for the Cap IgG and 5-weeks-post farrowing for the Rep IgG using Cap- and Rep-specific enzyme linked immunosorbent assays (ELISA) and immunofluorescent assays (IFA) methods. Following experimental inoculation, Cap IgG was detected at 2-weeks-post inoculation and Rep IgG detection was delayed until 4-weeks-post inoculation. Furthermore, convalescent serum from either PCV2 or PCV3 methods displayed no cross-reactivity by serological methods against the other PCV. The information gained in this study highlights the development of both the Cap- and Rep-specific antibodies following experimental infection and through the transfer of maternal antibodies. The increased understanding of the dynamics of maternal antibody transfer and development of the humoral response following infection gained in the present study may aid in the establishment of husbandry practices and potential application of prophylactics to control PCV3 clinical disease. IMPORTANCE Research on Porcine Circovirus 3 (PCV3) immunology is vital for understanding and controlling this virus. Previous studies primarily relied on field observations, but they have shown conflicting results about the immunological response against PCV3. This study helps fill those gaps by looking at how antibodies develop in pigs, especially those maternal-derived, and their impact in neonatal pigs preventing PCV3-associated disease in piglets. In addition, we look at the dynamics of antibodies in experimental infections mimicking infection in pigs in the grower-phase condition. Understanding this process can help to develop better strategies to prevent PCV3 infection. Also, this research found that PCV2 and PCV3 do not cross-react, which is crucial for serological test development and results interpretation. Overall, this work is essential for improving swine health and farming practices in the face of PCV3 infections.

Antibody Repertoire Development in Fetal and Neonatal Piglets. XV. Porcine Circovirus Type 2 Infection Differentially Affects Serum IgG Levels and Antibodies to ORF2 in Piglets Free from Other Environmental Factors.

Effects of Specific IgY Antibodies Against PRRSV and PCV-2-Cap Protein on Growth Performance and Immunity of Weaning Piglets

The porcine circovirus 3 humoral response: characterization of maternally derived antibodies and dynamic following experimental infection

Protective Immunity Induced by a Chimeric Porcine Circovirus in Piglets

Immune Response to Type-2 Porcine Circovirus in Weaned Pigs

Antibody Repertoire Development in Fetal and Neonatal Piglets. XVI. Influenza Stimulates Adaptive Immunity, Class Switch and Diversification of the IgG Repertoire Encoded by Downstream Cγ Genes.

Cytokine Mrna Expression Profiles in Peripheral Blood Mononuclear Cells from Piglets Experimentally Co-Infected with Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus Type 2

The effect of maternal antibody on changes of the virus copy number and immune response in PCV2-infected piglets

Cytokine mRNA expression profiles in peripheral blood mononuclear cells from piglets experimentally co-infected with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.

Immune response in piglets orally immunized with recombinant Bacillus subtilis expressing the capsid protein of porcine circovirus type 2

Association of concurrent porcine circovirus (PCV) 2a and 2b infection with PCV associated disease in vaccinated pigs.

Dynamics of PCV2 and PCV3 in the Serum and Oral Fluids of Pigs After PCV2 Vaccination in a Commercial Farm

Studies on porcine circovirus type 2 vaccination of 5-day-old piglets

Does Circulating Antibody Play a Role in the Protection of Piglets against Porcine Epidemic Diarrhea Virus?

A Pcv2 Vaccine Based on Genotype 2b is More Effective Than A 2A-Based Vaccine to Protect Against Pcv2b or Combined Pcv2a/2b Viremia in Pigs with Concurrent Pcv2, Prrsv and Ppv Infection

Serum and Mammary Secretion Antibody Responses in Porcine Epidemic Diarrhea-Immune Gilts Following Porcine Epidemic Diarrhea Vaccination

Changes in peripheral blood leukocyte subpopulations in piglets co-infected experimentally with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2

Comparative infectivity and horizontal transmission ability of the isolates PCV2a, PCV2b, and PCV2d

PRRSV-Vaccinated, Seronegative Sows and Maternally Derived Antibodies (I): Impact on PRRSV-1 Challenge Outcomes in Piglets

Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets

The Effects of PCV2 Experimental Infection on Transcriptional Levels of IL-2, IL-4,IL-10, IL-12p40, IFN-γ and TNF-α Mrna of Peripheral Blood Lymphocytes